Precision Net Borrowings from 2010 to 2024

DTIL Stock  USD 7.24  0.02  0.28%   
Precision BioSciences Net Borrowings yearly trend continues to be quite stable with very little volatility. Net Borrowings may rise above about 20.6 M this year. Net Borrowings is the difference between the amount of new debt Precision BioSciences has taken on and the amount of debt it has paid off during a given period. View All Fundamentals
 
Net Borrowings  
First Reported
2010-12-31
Previous Quarter
17.8 M
Current Value
20.6 M
Quarterly Volatility
14.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Precision BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precision BioSciences' main balance sheet or income statement drivers, such as Interest Income of 8.2 M, Interest Expense of 2.3 M or Selling General Administrative of 29 M, as well as many indicators such as Price To Sales Ratio of 0.82, Dividend Yield of 0.0 or PTB Ratio of 2.34. Precision financial statements analysis is a perfect complement when working with Precision BioSciences Valuation or Volatility modules.
  
Check out the analysis of Precision BioSciences Correlation against competitors.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.

Latest Precision BioSciences' Net Borrowings Growth Pattern

Below is the plot of the Net Borrowings of Precision BioSciences over the last few years. It is the difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period. Precision BioSciences' Net Borrowings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Precision BioSciences' overall financial position and show how it may be relating to other accounts over time.
Net Borrowings10 Years Trend
Slightly volatile
   Net Borrowings   
       Timeline  

Precision Net Borrowings Regression Statistics

Arithmetic Mean30,411,449
Coefficient Of Variation47.41
Mean Deviation12,184,735
Median39,550,000
Standard Deviation14,418,316
Sample Variance207.9T
Range39.6M
R-Value(0.70)
Mean Square Error114.4T
R-Squared0.49
Significance0
Slope(2,254,351)
Total Sum of Squares2910.4T

Precision Net Borrowings History

202420.6 M
202317.8 M
202219.8 M
2021-48 K
20202.5 M

About Precision BioSciences Financial Statements

Precision BioSciences investors utilize fundamental indicators, such as Net Borrowings, to predict how Precision Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Borrowings17.8 M20.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
Check out the analysis of Precision BioSciences Correlation against competitors.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.4
Revenue Per Share
12.872
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.06)
Return On Equity
0.2444
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.